Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis ; volume:35 ; number:9 ; day:9 ; month:8 ; year:2021 ; pages:985-997 ; date:9.2021
CNS drugs ; 35, Heft 9 (9.8.2021), 985-997, 9.2021
- Urheber
-
Bar-Or, Amit
O’Brien, Susan M.
Sweeney, Michael L.
Fox, Edward J.
Cohen, Jeffrey A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-021-00843-8
- URN
-
urn:nbn:de:101:1-2021111407061624750546
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bar-Or, Amit
- O’Brien, Susan M.
- Sweeney, Michael L.
- Fox, Edward J.
- Cohen, Jeffrey A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dental Adverse Effects of Anti-CD20 Therapies
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Review of pharmacological therapies in fibromyalgia syndrome
Review of pharmacological therapies in fibromyalgia syndrome
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Nutritional and pharmacological attributes of baobab fruit pulp
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany
Current and future pharmacological therapies for NAFLD/NASH
Current Disease-Modifying Therapies in Multiple Sclerosis
Cellular Therapies in Systemic Sclerosis: Recent Progress
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Dental Adverse Effects of Anti-CD20 Therapies
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Review of pharmacological therapies in fibromyalgia syndrome
Review of pharmacological therapies in fibromyalgia syndrome
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Nutritional and pharmacological attributes of baobab fruit pulp
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany
Current and future pharmacological therapies for NAFLD/NASH
Current Disease-Modifying Therapies in Multiple Sclerosis
Cellular Therapies in Systemic Sclerosis: Recent Progress
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Dental Adverse Effects of Anti-CD20 Therapies
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Review of pharmacological therapies in fibromyalgia syndrome
Review of pharmacological therapies in fibromyalgia syndrome
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Nutritional and pharmacological attributes of baobab fruit pulp
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany
Current and future pharmacological therapies for NAFLD/NASH
Current Disease-Modifying Therapies in Multiple Sclerosis
Cellular Therapies in Systemic Sclerosis: Recent Progress
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues